Works matching IS 09509232 AND DT 2015 AND VI 34 AND IP 40
Results: 10
TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells.
- Published in:
- Oncogene, 2015, v. 34, n. 40, p. 5163, doi. 10.1038/onc.2014.437
- By:
- Publication type:
- Article
Platelet-activating factor receptor-mediated PI3K/AKT activation contributes to the malignant development of esophageal squamous cell carcinoma.
- Published in:
- Oncogene, 2015, v. 34, n. 40, p. 5114, doi. 10.1038/onc.2014.434
- By:
- Publication type:
- Article
MUC1-C activates the TAK1 inflammatory pathway in colon cancer.
- Published in:
- Oncogene, 2015, v. 34, n. 40, p. 5187, doi. 10.1038/onc.2014.442
- By:
- Publication type:
- Article
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway.
- Published in:
- Oncogene, 2015, v. 34, n. 40, p. 5175, doi. 10.1038/onc.2014.441
- By:
- Publication type:
- Article
Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy.
- Published in:
- Oncogene, 2015, v. 34, n. 40, p. 5105, doi. 10.1038/onc.2014.458
- By:
- Publication type:
- Article
KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination.
- Published in:
- Oncogene, 2015, v. 34, n. 40, p. 5141, doi. 10.1038/onc.2014.435
- By:
- Publication type:
- Article
SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme.
- Published in:
- Oncogene, 2015, v. 34, n. 40, p. 5128, doi. 10.1038/onc.2014.439
- By:
- Publication type:
- Article
The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.
- Published in:
- Oncogene, 2015, v. 34, n. 40, p. 5206, doi. 10.1038/onc.2015.314
- By:
- Publication type:
- Article
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.
- Published in:
- Oncogene, 2015, v. 34, n. 40, p. 5198, doi. 10.1038/onc.2014.443
- By:
- Publication type:
- Article
p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death.
- Published in:
- Oncogene, 2015, v. 34, n. 40, p. 5152, doi. 10.1038/onc.2014.436
- By:
- Publication type:
- Article